148 related articles for article (PubMed ID: 24901886)
1. CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy.
Luetkemeyer AF; Havlir DV; Currier JS
Top Antivir Med; 2014 May; 22(2):602-15. PubMed ID: 24901886
[TBL] [Abstract][Full Text] [Related]
2. CROI 2013: Complications of HIV disease, viral hepatitis, and antiretroviral therapy.
Luetkemeyer AF; Havlir DV; Currier JS
Top Antivir Med; 2013; 21(2):62-74. PubMed ID: 23681961
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic HCV genotype 1 coinfection.
Boesecke C; Rockstroh JK
Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
[TBL] [Abstract][Full Text] [Related]
4. Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Naggie S; Cooper C; Saag M; Workowski K; Ruane P; Towner WJ; Marks K; Luetkemeyer A; Baden RP; Sax PE; Gane E; Santana-Bagur J; Stamm LM; Yang JC; German P; Dvory-Sobol H; Ni L; Pang PS; McHutchison JG; Stedman CA; Morales-Ramirez JO; Bräu N; Jayaweera D; Colson AE; Tebas P; Wong DK; Dieterich D; Sulkowski M;
N Engl J Med; 2015 Aug; 373(8):705-13. PubMed ID: 26196665
[TBL] [Abstract][Full Text] [Related]
5. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
[TBL] [Abstract][Full Text] [Related]
6. CROI 2016: Viral Hepatitis and Liver Fibrosis.
Luetkemeyer AF; Wyles DL
Top Antivir Med; 2016; 24(1):47-58. PubMed ID: 27398862
[TBL] [Abstract][Full Text] [Related]
7. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
[TBL] [Abstract][Full Text] [Related]
8. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.
Neukam K; Morano-Amado LE; Rivero-Juárez A; Mancebo M; Granados R; Téllez F; Collado A; Ríos MJ; de Los Santos-Gil I; Reus-Bañuls S; Vera-Méndez F; Geijo-Martínez P; Montero-Alonso M; Suárez-Santamaría M; Pineda JA
HIV Clin Trials; 2017 May; 18(3):126-134. PubMed ID: 28599618
[TBL] [Abstract][Full Text] [Related]
9. Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks.
Corma-Gómez A; Macías J; Merino Muñoz D; Téllez F; Granados R; Morano LE; De Los Santos Gil I; Vera-Méndez FJ; Collado A; Palacios R; Pineda JA
J Infect; 2019 Jul; 79(1):30-35. PubMed ID: 31100364
[TBL] [Abstract][Full Text] [Related]
10. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Wyles DL; Ruane PJ; Sulkowski MS; Dieterich D; Luetkemeyer A; Morgan TR; Sherman KE; Dretler R; Fishbein D; Gathe JC; Henn S; Hinestrosa F; Huynh C; McDonald C; Mills A; Overton ET; Ramgopal M; Rashbaum B; Ray G; Scarsella A; Yozviak J; McPhee F; Liu Z; Hughes E; Yin PD; Noviello S; Ackerman P;
N Engl J Med; 2015 Aug; 373(8):714-25. PubMed ID: 26196502
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients.
De Leon LB; Tovo CV; Kliemann DA; De Mattos AA; Feltrin AA; Pacheco LS; De Almeida PR
J Infect Dev Ctries; 2016 Aug; 10(7):762-9. PubMed ID: 27482809
[TBL] [Abstract][Full Text] [Related]
12. Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).
Ingiliz P; Christensen S; Kimhofer T; Hueppe D; Lutz T; Schewe K; Busch H; Schmutz G; Wehmeyer MH; Boesecke C; Simon KG; Berger F; Rockstroh JK; Schulze zur Wiesch J; Baumgarten A; Mauss S
Clin Infect Dis; 2016 Nov; 63(10):1320-1324. PubMed ID: 27535952
[TBL] [Abstract][Full Text] [Related]
13. Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.
Miailhes P; Hartig-Lavie K; Virlogeux V; Pradat P; Diakite M; Uhres AC; Zoulim F; Sarda MN
Clin Microbiol Infect; 2018 Nov; 24(11):1215.e1-1215.e4. PubMed ID: 29870852
[TBL] [Abstract][Full Text] [Related]
14. A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
Braun DL; Rauch A; Aouri M; Durisch N; Eberhard N; Anagnostopoulos A; Ledergerber B; Müllhaupt B; Metzner KJ; Decosterd L; Böni J; Weber R; Fehr J;
PLoS One; 2015; 10(7):e0133028. PubMed ID: 26176696
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.
Bräu N
J Antimicrob Chemother; 2005 Dec; 56(6):991-5. PubMed ID: 16308419
[TBL] [Abstract][Full Text] [Related]
16. Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection.
Montes ML; Olveira A; Ahumada A; Aldámiz T; García-Samaniego J; Clemente A; Berenguer J; González-García J; Martín-Carbonero L;
AIDS; 2017 Jun; 31(9):1253-1260. PubMed ID: 28358742
[TBL] [Abstract][Full Text] [Related]
17. Advances in the treatment of HIV/HCV coinfection in adults.
Schlabe S; Rockstroh JK
Expert Opin Pharmacother; 2018 Jan; 19(1):49-64. PubMed ID: 29252031
[TBL] [Abstract][Full Text] [Related]
18. Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial.
Rockstroh JK; Bhagani S; Hyland RH; Yun C; Dvory-Sobol H; Zheng W; Brainard DM; Ingiliz P; Lutz T; Boesecke C; Nelson M
Lancet Gastroenterol Hepatol; 2017 May; 2(5):347-353. PubMed ID: 28397698
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatitis C: a systematic review.
Kohli A; Shaffer A; Sherman A; Kottilil S
JAMA; 2014 Aug; 312(6):631-40. PubMed ID: 25117132
[TBL] [Abstract][Full Text] [Related]
20. Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients.
Del Bello D; Ita Nagy F; Hand J; Khedemi R; Lécluse-Barth J; Dieterich D; Piroth L
Curr Opin HIV AIDS; 2015 Sep; 10(5):337-47. PubMed ID: 26248121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]